A detailed history of Vanguard Group Inc transactions in Surmodics Inc stock. As of the latest transaction made, Vanguard Group Inc holds 803,827 shares of SRDX stock, worth $30.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
803,827
Previous 865,214 7.1%
Holding current value
$30.2 Million
Previous $25.4 Million 33.12%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$25.39 - $42.1 $1.56 Million - $2.58 Million
-61,387 Reduced 7.1%
803,827 $33.8 Million
Q1 2024

May 10, 2024

BUY
$27.44 - $35.56 $162,636 - $210,764
5,927 Added 0.69%
865,214 $25.4 Million
Q4 2023

Feb 14, 2024

BUY
$28.47 - $38.49 $373,611 - $505,104
13,123 Added 1.55%
859,287 $31.2 Million
Q3 2023

Nov 14, 2023

BUY
$28.28 - $38.36 $555,277 - $753,198
19,635 Added 2.38%
846,164 $27.2 Million
Q2 2023

Aug 14, 2023

BUY
$17.67 - $31.31 $249,853 - $442,723
14,140 Added 1.74%
826,529 $25.9 Million
Q1 2023

May 15, 2023

SELL
$17.13 - $38.52 $2.96 Million - $6.65 Million
-172,522 Reduced 17.52%
812,389 $18.5 Million
Q4 2022

Feb 10, 2023

BUY
$29.44 - $37.31 $299,846 - $380,002
10,185 Added 1.04%
984,911 $33.6 Million
Q3 2022

Nov 14, 2022

BUY
$28.84 - $38.92 $457,604 - $617,543
15,867 Added 1.65%
974,726 $29.6 Million
Q2 2022

Aug 12, 2022

BUY
$33.25 - $45.11 $931,698 - $1.26 Million
28,021 Added 3.01%
958,859 $35.7 Million
Q1 2022

May 13, 2022

BUY
$40.68 - $49.72 $968,102 - $1.18 Million
23,798 Added 2.62%
930,838 $42.2 Million
Q4 2021

Feb 14, 2022

SELL
$43.21 - $57.6 $1.02 Million - $1.36 Million
-23,638 Reduced 2.54%
907,040 $43.7 Million
Q3 2021

Nov 12, 2021

SELL
$52.8 - $60.32 $2.5 Million - $2.86 Million
-47,436 Reduced 4.85%
930,678 $51.7 Million
Q2 2021

Aug 13, 2021

BUY
$51.29 - $59.15 $50.2 Million - $57.9 Million
978,114 New
978,114 $53.1 Million

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $527M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.